From: A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa
Recruitment and screening | n | % | n | % | n | % | n | % |
---|---|---|---|---|---|---|---|---|
Recruitment method | Point-of-care screening | Traced | Referred In | Total | ||||
HCV | ||||||||
Anti-HCV assessment | 163 | 163 | ||||||
Anti-HCV positive | 107 | 65.6% | 29 | 8 | 144 | |||
HCV viremia assessment | 90 | 84.1% | 29 | 100.0% | 8 | 100.0% | 127 | 88.2% |
HCV detected, i.e., viremic | 80 | 87.0% | 29 | 100.0% | 7 | 87.5% | 116 | 91.3% |
HCV RNA undetected | 8 | 8.7% | 1 | 12.5% | 9 | 7.1% | ||
HCV RNA uninterpretable | 2 | 2.2% | 2 | 1.6% | ||||
HIV | ||||||||
HIV1/2 assessment | 142 | 87.1% | 29 | 100.0% | 7 | 87.5% | 178 | |
HIV1/2 positive | 59 | 41.5% | 12 | 41.4% | 5 | 71.4% | 76 | 42.7% |
HBV | ||||||||
HBsAg assessment | 121 | 74.2% | 29 | 100.0% | 8 | 100.0% | 158 | 79.0% |
HBsAg positive | 6 | 2.0% | 2 | 6.9% | 3 | 37.5% | 11 | 7.0% |